8 Recruiting Crohn's Disease Clinical Trials in California
Explore active crohn's disease research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Crohn's Disease Studies in California
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
📍 Center for Colitis and Crohns Disease University of California — San Francisco, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
OTIS Cimzia Pregnancy Registry
📍 University of California, San Diego — San Diego, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program
Online Pain Education for Crohn's Disease and Ulcerative Colitis
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
📍 UCSD Medical Center — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
📍 UCSF Benioff Children's Hospital - Oakland /ID# 262217 — Oakland, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
📍 United Medical Doctors — Murrieta, California
View Study & Checklist ➔